Aramoto H, Shigematsu H, Muto T
First Department of Surgery, Faculty of Medicine, University of Tokyo, Japan.
Int J Cardiol. 1994 Dec;47(1 Suppl):S55-63. doi: 10.1016/0167-5273(94)90327-1.
To determine the factors which influence perioperative coagulative and fibrinolytic function, we studied 41 patients who underwent surgical repair of unruptured abdominal aortic aneurysm (AAA) and 30 patients who underwent arterial reconstruction for arteriosclerosis obliterans (ASO). In patients with AAA, the levels of fibrin/fibrinogen degradation products (FDP) (11.4 +/- 20.1 micrograms/ml), thrombin-antithrombin III complex (TAT) (22.0 +/- 21.8 micrograms/l), plasmin-alpha 2 plasmin inhibitor complex (PIC) (2.6 +/- 2.9 micrograms/ml) and d-dimer of cross-linked fibrin degradation products (D-D) (8.4 +/- 10.8 micrograms/ml) were elevated, particularly when the AAAs had a large mural thrombus surface area or were accompanied by aneurysm of the iliac or femoral artery. In arterial aneurysms, blood coagulability and secondary fibrinolytic activity were believed to be enhanced. In patients with ASO, the level of TAT (17.2 +/- 24.8 micrograms/l) was so elevated that they were considered to show chronic hypercoagulability. Among the ASO patients with aorto-iliac lesions, those with concomitant graft occlusion or anastomotic aneurysm had significantly elevated levels of TAT. Proximal arterial occlusion or accompanying aneurysm in the ASO patients was associated with increased levels of PIC and D-D. Postoperative fluctuations in conventional hematological variables did not differ significantly among the surgical procedures. Conventional markers showed a transient decrease due to consumption during surgery, and a subsequent recovery or an actual increase within several days after surgery.(ABSTRACT TRUNCATED AT 250 WORDS)
为了确定影响围手术期凝血和纤溶功能的因素,我们研究了41例行未破裂腹主动脉瘤(AAA)手术修复的患者和30例行动脉硬化闭塞症(ASO)动脉重建术的患者。在AAA患者中,纤维蛋白/纤维蛋白原降解产物(FDP)水平(11.4±20.1微克/毫升)、凝血酶 - 抗凝血酶III复合物(TAT)水平(22.0±21.8微克/升)、纤溶酶-α2纤溶酶抑制物复合物(PIC)水平(2.6±2.9微克/毫升)和交联纤维蛋白降解产物的D-二聚体(D-D)水平(⑧.4±10.8微克/毫升)升高,尤其是当AAA有较大的壁血栓表面积或伴有髂动脉或股动脉瘤时。在动脉动脉瘤中,血液凝固性和继发性纤溶活性被认为增强。在ASO患者中,TAT水平(17.2±24.8微克/升)升高到被认为表现为慢性高凝状态。在患有主-髂病变的ASO患者中,伴有移植物闭塞或吻合口动脉瘤的患者TAT水平显著升高。ASO患者的近端动脉闭塞或伴发动脉瘤与PIC和D-D水平升高有关。不同手术方式术后传统血液学变量的波动无显著差异。传统指标因手术中的消耗而出现短暂下降,随后在术后数天内恢复或实际升高。(摘要截短至250字) (注:原文中“⑧.4”疑似有误,应为“8.4”,译文按8.4翻译)